I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 22 studies | 35% ± 18% | |
| oligodendrocyte | 11 studies | 34% ± 12% | |
| astrocyte | 10 studies | 33% ± 15% | |
| oligodendrocyte precursor cell | 10 studies | 36% ± 15% | |
| ciliated cell | 8 studies | 25% ± 8% | |
| basal cell | 6 studies | 28% ± 9% | |
| gamma-delta T cell | 6 studies | 31% ± 13% | |
| club cell | 5 studies | 24% ± 7% | |
| natural killer cell | 5 studies | 24% ± 6% | |
| microglial cell | 5 studies | 21% ± 2% | |
| GABAergic neuron | 4 studies | 28% ± 6% | |
| epithelial cell | 4 studies | 46% ± 18% | |
| endothelial cell | 3 studies | 22% ± 5% | |
| precursor B cell | 3 studies | 33% ± 11% | |
| squamous epithelial cell | 3 studies | 44% ± 18% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 4% | |
| respiratory goblet cell | 3 studies | 29% ± 5% | |
| glutamatergic neuron | 3 studies | 37% ± 3% | |
| T cell | 3 studies | 25% ± 3% | |
| macrophage | 3 studies | 18% ± 2% |
